Discover 1,917 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,917
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer
Location: Fort Worth TX, Houston TX, Atlanta GA, Tampa FL,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07659782
Phase2, Recruiting
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
for
Metastatic Castration-Resistant Prostate Cancer
Location: Dallas TX, Houston TX, New Orleans LA, Albuquerque NM,
Sponsor: Kyntra Bio
Sex: Male
Age: 18+
Code: NCT06842498
Phase2, Recruiting
A Study to Evaluate the Efficacy and Safety of Subcutaneous Nomlabofusp in Subjects With Friedreich's Ataxia
for
Friedreich Ataxia, Friedreich's Ataxia
Location: Dallas TX, Chicago IL, Eatontown NJ
Sponsor: Larimar Therapeutics, Inc.
Sex: All
Age: 12 - 40
Code: NCT07778836
Phase3, Recruiting
Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis
for
Locally Advanced Renal Cell Carcinoma
Location: Dallas TX, St Louis MO, Richmond VA
Sponsor: Qian Qin
Sex: All
Age: 18+
Code: NCT06794229
Phase2, Recruiting
DALY II USA/ MB-CART2019.1 for DLBCL
for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Dallas TX, Houston TX, San Antonio TX, Westwood KS,
Sponsor: Miltenyi Biomedicine GmbH
Sex: All
Age: 18+
Code: NCT04792489
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration
for
Tetraplegia/Tetraparesis, Quadriplegia,
Location: Dallas TX
Sponsor: Neuralink Corp
Sex: All
Age: 22 - 70+
Code: NCT07224256
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Cancer, PDAC,
Location: Dallas TX, Longview TX, Lawrence KS, Kansas City MO,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07252232
Phase3, Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
for
SLE, SLE (Systemic Lupus)
Location: Plano TX, Webster TX, Memphis TN, Iowa City IA,
Sponsor: Cullinan Therapeutics Inc.
Sex: All
Age: 18 - 70
Code: NCT06613360
Phase1, Recruiting
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
for
Triple Negative Breast Cancer
Location: Dallas TX, Germantown TN, Westwood KS, St Louis MO,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06926920
Phase1, Phase2, Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Location: Dallas TX, Houston TX, Memphis TN, Atlanta GA,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 2 - 30
Code: NCT05734066
Phase1, Phase2, Recruiting
A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation
for
Microvascular Inflammation
Location: Dallas TX, Houston TX, Kansas City KS, St Louis MO,
Sponsor: Biogen
Sex: All
Age: 18 - 70+
Code: NCT07219043
Phase2, Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),